• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板在动脉粥样硬化冠状动脉上的沉积增加。

Increased platelet deposition on atherosclerotic coronary arteries.

作者信息

van Zanten G H, de Graaf S, Slootweg P J, Heijnen H F, Connolly T M, de Groot P G, Sixma J J

机构信息

Department of Hematology, University Hospital Utrecht, The Netherlands.

出版信息

J Clin Invest. 1994 Feb;93(2):615-32. doi: 10.1172/JCI117014.

DOI:10.1172/JCI117014
PMID:8113399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC293885/
Abstract

A ruptured atherosclerotic plaque leads to exposure of deeper layers of the plaque to flowing blood and subsequently to thrombus formation. In contrast to the wealth of data on the occurrence of thrombi, little is known about the reasons why an atherosclerotic plaque is thrombogenic. One of the reasons is the relative inaccessibility of the atherosclerotic plaque. We have circumvented this problem by using 6-microns cryostat cross sections of human coronary arteries. These sections were mounted on coverslips that were exposed to flowing blood in a rectangular perfusion chamber. In normal-appearing arteries, platelet deposition was seen on the luminal side of the intima and on the adventitia. In atherosclerotic arteries, strongly increased platelet deposition was seen on the connective tissue of specific parts of the atherosclerotic plaque. The central lipid core of an advanced plaque was not reactive towards platelets. The results indicate that the atherosclerotic plaque by itself is more thrombogenic than the normal vessel wall. To study the cause of the increased thrombus formation on the atherosclerotic plaque, perfusion studies were combined with immunohistochemical studies. Immunohistochemical studies of adhesive proteins showed enrichment of collagen types I, III, V, and VI, vitronectin, fibronectin, fibrinogen/fibrin, and thrombospondin in the atherosclerotic plaque. Laminin and collagen type IV were not enriched. von Willebrand Factor (vWF) was not present in the plaque. The pattern of increased platelet deposition in serial cross sections corresponded best with areas in which collagen types I and III were enriched, but there were also areas in the plaque where both collagens were enriched but no increased reactivity was seen. Inhibition of platelet adhesion with a large range of antibodies or specific inhibitors showed that vWF from plasma and collagen types I and/or III in the plaque were involved. Fibronectin from plasma and fibronectin, fibrinogen, laminin, and thrombospondin in the vessel wall had no effect on platelet adhesion. We conclude that the increased thrombogenicity of atherosclerotic lesions is due to changes in quantity and nature of collagen types I and/or III.

摘要

破裂的动脉粥样硬化斑块会使斑块深层暴露于流动的血液中,随后导致血栓形成。与关于血栓形成的数据丰富相比,对于动脉粥样硬化斑块具有血栓形成倾向的原因却知之甚少。原因之一是动脉粥样硬化斑块相对难以触及。我们通过使用人类冠状动脉6微米厚的低温恒温器切片解决了这个问题。这些切片被安装在盖玻片上,放置在矩形灌注室中暴露于流动的血液中。在外观正常的动脉中,在内膜腔面和外膜上可见血小板沉积。在动脉粥样硬化的动脉中,在动脉粥样硬化斑块特定部位的结缔组织上可见血小板沉积显著增加。晚期斑块的中央脂质核心对血小板无反应。结果表明,动脉粥样硬化斑块本身比正常血管壁更具血栓形成倾向。为了研究动脉粥样硬化斑块上血栓形成增加的原因,将灌注研究与免疫组织化学研究相结合。对黏附蛋白的免疫组织化学研究表明,动脉粥样硬化斑块中I型、III型、V型和VI型胶原蛋白、玻连蛋白、纤连蛋白、纤维蛋白原/纤维蛋白和血小板反应蛋白富集。层粘连蛋白和IV型胶原蛋白未富集。斑块中不存在血管性血友病因子(vWF)。连续切片中血小板沉积增加的模式与I型和III型胶原蛋白富集的区域最相符,但斑块中也存在两种胶原蛋白都富集但未见反应性增加的区域。用多种抗体或特异性抑制剂抑制血小板黏附表明,血浆中的vWF以及斑块中的I型和/或III型胶原蛋白参与其中。血浆中的纤连蛋白以及血管壁中的纤连蛋白、纤维蛋白原、层粘连蛋白和血小板反应蛋白对血小板黏附无影响。我们得出结论,动脉粥样硬化病变血栓形成倾向增加是由于I型和/或III型胶原蛋白的数量和性质发生了变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/7f9dbd635c27/jcinvest00031-0181-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/08c6b4771d52/jcinvest00031-0170-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/c2eca32a1a17/jcinvest00031-0170-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/329fd1b4539e/jcinvest00031-0171-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/039a2f97c3e9/jcinvest00031-0171-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/d1145ec60d6c/jcinvest00031-0172-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/abceca0a0d16/jcinvest00031-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/9fd86e27da40/jcinvest00031-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/1d0a434f3059/jcinvest00031-0176-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/fa8ec4478f45/jcinvest00031-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/d7ee3ee2d836/jcinvest00031-0177-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/c4b0b23fc213/jcinvest00031-0178-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/a89e47f95175/jcinvest00031-0178-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/3890ea58b718/jcinvest00031-0180-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/c8ce21ba1f35/jcinvest00031-0180-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/f9a5fa3aaa9b/jcinvest00031-0181-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/0782a3603ff9/jcinvest00031-0181-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/8f92a0cb5c77/jcinvest00031-0181-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/04c355273164/jcinvest00031-0181-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/69cf66af86bf/jcinvest00031-0181-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/7f9dbd635c27/jcinvest00031-0181-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/08c6b4771d52/jcinvest00031-0170-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/c2eca32a1a17/jcinvest00031-0170-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/329fd1b4539e/jcinvest00031-0171-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/039a2f97c3e9/jcinvest00031-0171-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/d1145ec60d6c/jcinvest00031-0172-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/abceca0a0d16/jcinvest00031-0175-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/9fd86e27da40/jcinvest00031-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/1d0a434f3059/jcinvest00031-0176-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/fa8ec4478f45/jcinvest00031-0177-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/d7ee3ee2d836/jcinvest00031-0177-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/c4b0b23fc213/jcinvest00031-0178-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/a89e47f95175/jcinvest00031-0178-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/3890ea58b718/jcinvest00031-0180-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/c8ce21ba1f35/jcinvest00031-0180-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/f9a5fa3aaa9b/jcinvest00031-0181-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/0782a3603ff9/jcinvest00031-0181-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/8f92a0cb5c77/jcinvest00031-0181-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/04c355273164/jcinvest00031-0181-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/69cf66af86bf/jcinvest00031-0181-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c143/293885/7f9dbd635c27/jcinvest00031-0181-f.jpg

相似文献

1
Increased platelet deposition on atherosclerotic coronary arteries.血小板在动脉粥样硬化冠状动脉上的沉积增加。
J Clin Invest. 1994 Feb;93(2):615-32. doi: 10.1172/JCI117014.
2
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.凝血因子VIII-血管性血友病因子和纤连蛋白在流动血液中血小板与单体及纤维状I型和III型人胶原蛋白相互作用中的作用。
J Clin Invest. 1985 Feb;75(2):531-40. doi: 10.1172/JCI111729.
3
Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.流动条件下肾病综合征中的血栓形成及血小板与血管壁的相互作用
J Clin Invest. 1994 Jan;93(1):204-11. doi: 10.1172/JCI116947.
4
Platelet adhesion.血小板黏附
Prog Hemost Thromb. 1984;7:211-88.
5
The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.HMEC-1细胞系的内皮下层在缺乏血管性血友病因子以及I、III和VI型胶原的情况下支持血栓形成。
Thromb Haemost. 2001 Mar;85(3):552-9.
6
Human atheromatous plaques stimulate thrombus formation by activating platelet glycoprotein VI.人类动脉粥样硬化斑块通过激活血小板糖蛋白VI刺激血栓形成。
FASEB J. 2005 Jun;19(8):898-909. doi: 10.1096/fj.04-2748com.
7
Initial interactions of platelets and plasma proteins in flowing non-anticoagulated human blood with the artificial surfaces Dacron and PTFE.在流动的未抗凝人血中,血小板和血浆蛋白与涤纶和聚四氟乙烯等人工表面的初始相互作用。
Blood Coagul Fibrinolysis. 1994 Jun;5(3):355-63.
8
Inflammation in atheroma: implications for plaque rupture and platelet-collagen interaction.动脉粥样硬化中的炎症:对斑块破裂和血小板 - 胶原蛋白相互作用的影响。
Eur Heart J. 1993 Dec;14 Suppl K:94-7.
9
Platelet adhesion to collagen type I, collagen type IV, von Willebrand factor, fibronectin, laminin and fibrinogen: rapid kinetics under shear.血小板与I型胶原蛋白、IV型胶原蛋白、血管性血友病因子、纤连蛋白、层粘连蛋白和纤维蛋白原的黏附:剪切力作用下的快速动力学
Thromb Haemost. 1999 Jan;81(1):118-23.
10
Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis.纤维蛋白原、纤维蛋白及纤维蛋白降解产物与动脉粥样硬化的关系
Clin Haematol. 1986 May;15(2):355-70.

引用本文的文献

1
A humanised thrombus-on-a-chip model utilising tissue-engineered arterial constructs: A method to reduce and replace mice used in thrombosis and haemostasis research.一种利用组织工程动脉构建体的人源化芯片上血栓模型:一种减少和替代用于血栓形成和止血研究的小鼠的方法。
F1000Res. 2025 Jan 20;14:110. doi: 10.12688/f1000research.158910.1. eCollection 2025.
2
Developing a Biomimetic 3D Neointimal Layer as a Prothrombotic Substrate for a Humanized In Vitro Model of Atherothrombosis.构建仿生3D新生内膜层作为动脉粥样硬化血栓形成人源化体外模型的促血栓形成底物。
Biomimetics (Basel). 2024 Jun 20;9(6):372. doi: 10.3390/biomimetics9060372.
3

本文引用的文献

1
Thromboplastin activities of human arterial and venous tissues.
Proc Soc Exp Biol Med. 1962 Apr;109:890-2. doi: 10.3181/00379727-109-27369.
2
CONTRIBUTION OF ATHEROMATOUS GRUEL TO THROMBUS FORMATION.粥样糜粥样物对血栓形成的作用。
Proc Soc Exp Biol Med. 1964 Feb;115:436-8. doi: 10.3181/00379727-115-28934.
3
Thrombospondin-platelet interactions. Role of divalent cations, wall shear rate, and platelet membrane glycoproteins.血小板反应蛋白与血小板的相互作用。二价阳离子、壁剪切速率和血小板膜糖蛋白的作用。
Anti-GPVI nanobody blocks collagen- and atherosclerotic plaque-induced GPVI clustering, signaling, and thrombus formation.
抗 GpVI 纳米抗体阻断胶原和动脉粥样硬化斑块诱导的 GpVI 聚集、信号转导和血栓形成。
J Thromb Haemost. 2022 Nov;20(11):2617-2631. doi: 10.1111/jth.15836. Epub 2022 Aug 12.
4
Characterization of Atherosclerotic Plaque Coating for Thrombosis Microfluidics Assays.用于血栓形成微流控分析的动脉粥样硬化斑块涂层的表征
Cell Mol Bioeng. 2021 Oct 27;15(1):55-65. doi: 10.1007/s12195-021-00713-9. eCollection 2022 Feb.
5
In vitro Research of the Concentration Dependence of Effect of Adrenaline on Platelets Aggregation.肾上腺素对血小板聚集作用的浓度依赖性的体外研究
Curr Health Sci J. 2017 Jan-Mar;43(1):41-46. doi: 10.12865/CHSJ.43.01.06. Epub 2017 Sep 27.
6
Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation.抗Fc抗体交联糖蛋白VI-Fc增强其对动脉粥样硬化斑块和胶原蛋白诱导的血小板活化的抑制作用。
JACC Basic Transl Sci. 2016 Apr 25;1(3):131-142.. doi: 10.1016/j.jacbts.2016.03.008. eCollection 2016 Apr.
7
Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions.血小板PI3Kγ在严重血流减少条件下促成颈动脉内膜中层增厚。
PLoS One. 2015 Jun 8;10(6):e0129265. doi: 10.1371/journal.pone.0129265. eCollection 2015.
8
Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.二聚体GPVI-Fc和抗GPVI抗体对人动脉粥样硬化斑块诱导的血小板活化的差异性抑制:功能与成像研究
J Am Coll Cardiol. 2015 Jun 9;65(22):2404-15. doi: 10.1016/j.jacc.2015.03.573.
9
Identification of a novel mode of complement activation on stimulated platelets mediated by properdin and C3(H2O).鉴定补体在受刺激血小板上通过备解素和 C3(H2O)介导的新型激活方式。
J Immunol. 2013 Jun 15;190(12):6457-67. doi: 10.4049/jimmunol.1300610. Epub 2013 May 15.
10
State of the art in platelet function testing.血小板功能检测的最新技术进展。
Transfus Med Hemother. 2013 Apr;40(2):73-86. doi: 10.1159/000350469. Epub 2013 Mar 18.
J Clin Invest. 1993 Jul;92(1):288-96. doi: 10.1172/JCI116563.
4
Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.透壁性心肌梗死早期数小时内完全冠状动脉闭塞的发生率。
N Engl J Med. 1980 Oct 16;303(16):897-902. doi: 10.1056/NEJM198010163031601.
5
Heavy metal intensification of DAB-based HRP reaction product.基于二氨基联苯胺(DAB)的辣根过氧化物酶(HRP)反应产物的重金属强化
J Histochem Cytochem. 1981 Jun;29(6):775. doi: 10.1177/29.6.7252134.
6
Thrombin generation and fibrin formation following injury to rabbit neointima. Studies of vessel wall reactivity and platelet survival.兔新生内膜损伤后的凝血酶生成与纤维蛋白形成。血管壁反应性及血小板存活情况研究。
Lab Invest. 1982 Jun;46(6):605-12.
7
The distribution of collagen types I, III and V (AB) in normal and atherosclerotic human aorta.正常和动脉粥样硬化的人类主动脉中I型、III型和V型(AB)胶原蛋白的分布。
J Pathol. 1980 Jan;130(1):45-55. doi: 10.1002/path.1711300107.
8
Platelet adherence to subendothelium of human arteries in pulsatile and steady flow.血小板在脉动流和稳定流状态下对人动脉内皮下层的黏附。
Thromb Res. 1980;19(4-5):547-59. doi: 10.1016/0049-3848(80)90027-4.
9
Thrombogenicity of components of atheromatous material. An animal and in vitro model of cerebral atheroembolism.
Arch Pathol Lab Med. 1981 Jul;105(7):353-7.
10
Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi.伴有严重预先存在狭窄的斑块破裂引发冠状动脉血栓形成。致命性闭塞性血栓下冠状动脉粥样硬化斑块的特征。
Br Heart J. 1983 Aug;50(2):127-34. doi: 10.1136/hrt.50.2.127.